VERTEX PHARMACEUTICALS INC / MA·4

May 19, 2:21 PM ET

GARRISON RICHARD C 4

4 · VERTEX PHARMACEUTICALS INC / MA · Filed May 19, 2009

Insider Transaction Report

Form 4
Period: 2009-05-18
GARRISON RICHARD C
SVP and Catalyst
Transactions
  • Sale

    Common Stock

    2009-05-18$28.45/sh532$15,13537,473 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,309
Footnotes (3)
  • [F1]Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1.
  • [F2]Open market sales reported on this line occurred at a weighted average price of $28.45 (range $28.12 to $28.95).
  • [F3]Mr. Garrison undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT